Arkadios Wealth Advisors Buys Shares of 9,243 Encompass Health Corporation (NYSE:EHC)

Key Points

• Arkadios Wealth Advisors acquired 9,243 shares of Encompass Health Corporation, valued at approximately $936,000, during the first quarter of the year.
• Several hedge funds, including Vestcor Inc and LPL Financial LLC, have increased their stakes in Encompass Health, indicating strong institutional interest with 97.25% of the stock currently owned by institutional investors.
• Encompass Health recently announced an increase in its quarterly dividend from $0.17 to $0.19, reflecting an annualized yield of 0.7% for shareholders of record.

Arkadios Wealth Advisors bought a new stake in shares of Encompass Health Corporation (NYSE:EHC - Free Report) in the 1st quarter, according to its most recent filing with the SEC. The institutional investor bought 9,243 shares of the company's stock, valued at approximately $936,000.

Other institutional investors and hedge funds also recently made changes to their positions in the company. T. Rowe Price Investment Management Inc. bought a new stake in shares of Encompass Health in the 4th quarter worth approximately $152,953,000. Farallon Capital Management LLC increased its holdings in Encompass Health by 15,266.7% in the 4th quarter. Farallon Capital Management LLC now owns 461,000 shares of the company's stock valued at $42,573,000 after buying an additional 458,000 shares during the period. AQR Capital Management LLC lifted its holdings in shares of Encompass Health by 136.8% during the 4th quarter. AQR Capital Management LLC now owns 689,206 shares of the company's stock worth $63,648,000 after acquiring an additional 398,154 shares during the period. Price T Rowe Associates Inc. MD increased its stake in Encompass Health by 22.9% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 1,610,669 shares of the company's stock valued at $148,746,000 after acquiring an additional 300,386 shares during the period. Finally, Fuller & Thaler Asset Management Inc. lifted its stake in Encompass Health by 24.8% during the fourth quarter. Fuller & Thaler Asset Management Inc. now owns 1,378,077 shares of the company's stock worth $127,265,000 after purchasing an additional 274,192 shares during the period. Institutional investors own 97.25% of the company's stock.

Analyst Upgrades and Downgrades

Several brokerages recently issued reports on EHC. Royal Bank Of Canada lifted their price target on shares of Encompass Health from $110.00 to $125.00 and gave the company an "outperform" rating in a report on Monday, April 28th. KeyCorp upped their target price on shares of Encompass Health from $122.00 to $135.00 and gave the company an "overweight" rating in a research report on Tuesday, May 27th. Wall Street Zen lowered shares of Encompass Health from a "strong-buy" rating to a "buy" rating in a report on Friday, June 6th. Truist Financial reaffirmed a "buy" rating and issued a $135.00 price objective (up from $116.00) on shares of Encompass Health in a research report on Monday, April 28th. Finally, Barclays lifted their price objective on shares of Encompass Health from $118.00 to $129.00 and gave the company an "overweight" rating in a report on Friday, April 25th. Seven investment analysts have rated the stock with a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat.com, the stock has a consensus rating of "Buy" and an average price target of $133.17.

Encompass Health Stock Up 2.3%

Shares of Encompass Health stock traded up $2.66 on Wednesday, reaching $116.54. 1,081,286 shares of the company were exchanged, compared to its average volume of 829,044. Encompass Health Corporation has a one year low of $84.63 and a one year high of $123.13. The company has a current ratio of 1.06, a quick ratio of 1.06 and a debt-to-equity ratio of 0.81. The company has a 50-day moving average of $116.56 and a 200 day moving average of $108.30. The company has a market capitalization of $11.75 billion, a price-to-earnings ratio of 22.81, a PEG ratio of 2.22 and a beta of 0.86.

Encompass Health (NYSE:EHC - Get Free Report) last released its quarterly earnings data on Monday, August 4th. The company reported $1.40 EPS for the quarter, beating the consensus estimate of $1.20 by $0.20. The firm had revenue of $1.46 billion for the quarter, compared to the consensus estimate of $1.43 billion. Encompass Health had a net margin of 9.22% and a return on equity of 18.23%. The company's quarterly revenue was up 12.0% on a year-over-year basis. During the same period in the previous year, the company earned $1.11 earnings per share. On average, equities research analysts forecast that Encompass Health Corporation will post 4.8 earnings per share for the current year.

Encompass Health Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, October 15th. Investors of record on Wednesday, October 1st will be given a dividend of $0.19 per share. This is a positive change from Encompass Health's previous quarterly dividend of $0.17. This represents a $0.76 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date of this dividend is Wednesday, October 1st. Encompass Health's payout ratio is 14.05%.

Insider Buying and Selling

In other Encompass Health news, CEO Mark J. Tarr sold 118,384 shares of the stock in a transaction that occurred on Tuesday, May 20th. The shares were sold at an average price of $121.53, for a total transaction of $14,387,207.52. Following the transaction, the chief executive officer owned 527,070 shares in the company, valued at $64,054,817.10. This represents a 18.34% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Corporate insiders own 2.10% of the company's stock.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.